Hot Features
Premium
Level up your trading with our powerful tools and real-time insights all in one place.
Period:
Draw Mode:
| Volume | 9,377 |
|
|||||
| News | - |
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Apollomics Inc | APLMW | NASDAQ | Equity Warrant |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.0018 | 23.08% | 0.0096 | 18:30:44 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.0077 | 0.0077 | 0.0096 | 0.0096 | 0.0078 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume |
|---|---|---|---|---|
| 10 | 9,377 | 0.0077215 | 72 | - |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 15:00:00 | 200 | 0.0096 | USD |
Apollomics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 3.13M | 401.80M | - | 1.22M | -172.6M | -0.43 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News Apollomics
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
APLMW Historical
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Year | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 5 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| Apollomics Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. Apollomics has a pipeline of approximately nine drug candidates across multiple programs, six of which are in the clinical-stage of development. Apollomics' lead programs include investigating its core product, vebreltinib (APL-101), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other advanced tumors with c-Met alterations, which is in a Phase II multicohort clinical trial in the United States. The Company is also developing an anti-cancer enhancer drug candidate, uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia and other hematologic cancers. |
NASDAQ:APLMW -
What is the current Apollomics Inc share price?
The current share price of Apollomics Inc is US$ 0.0096
How many Apollomics Inc shares are in issue?
Apollomics Inc has 401,804,000 shares in issue
What is the market cap of Apollomics Inc?
The market capitalisation of Apollomics Inc is USD 3.13M
What is the 1 year trading range for Apollomics Inc share price?
Apollomics Inc has traded in the range of US$ 0.00 to US$ 0.00 during the past year
What is the PE ratio of Apollomics Inc?
The price to earnings ratio of Apollomics Inc is -13.43
What is the cash to sales ratio of Apollomics Inc?
The cash to sales ratio of Apollomics Inc is 1.92k
What is the reporting currency for Apollomics Inc?
Apollomics Inc reports financial results in USD
What is the latest annual turnover for Apollomics Inc?
The latest annual turnover of Apollomics Inc is USD 1.22M
What is the latest annual profit for Apollomics Inc?
The latest annual profit of Apollomics Inc is USD -172.6M
What is the registered address of Apollomics Inc?
The registered address for Apollomics Inc is 989 E. HILLSDALE BLVD, SUITE 220, FOSTER CITY, CALIFORNIA, 94404
What is the Apollomics Inc website address?
The website address for Apollomics Inc is www.apollomicsinc.com
Which industry sector does Apollomics Inc operate in?
Apollomics Inc operates in the PHARMACEUTICAL PREPARATIONS sector
